<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AS OF MARCH 31, 1996 AND CONSOLIDATED STATEMENT OF
INCOME FOR THE THREE MONTHS ENDED MARCH 31, 1997 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                             588
<SECURITIES>                                         0
<RECEIVABLES>                                    1,637
<ALLOWANCES>                                        32
<INVENTORY>                                      1,202
<CURRENT-ASSETS>                                 3,808
<PP&E>                                           4,075
<DEPRECIATION>                                   1,925
<TOTAL-ASSETS>                                   8,338
<CURRENT-LIABILITIES>                            2,840
<BONDS>                                          2,174
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           288
<OTHER-SE>                                       2,038
<TOTAL-LIABILITY-AND-EQUITY>                     8,338
<SALES>                                          1,443
<TOTAL-REVENUES>                                 1,443
<CGS>                                              782
<TOTAL-COSTS>                                      782
<OTHER-EXPENSES>                                   100<F1>
<LOSS-PROVISION>                                     1
<INTEREST-EXPENSE>                                  47
<INCOME-PRETAX>                                  (150)
<INCOME-TAX>                                        53
<INCOME-CONTINUING>                              (203)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (203)
<EPS-PRIMARY>                                    (.74)
<EPS-DILUTED>                                    (.74)<F2>
<FN>
<F1> For "Other-Expenses" - Ref #5-03(0)3 - 
     Includes R&D expense and goodwill amortization.
<F2> For the three months ended 3/31/97, common stock
     equivalents were anti-dilutive. Consequently,
     "EPS, fully diluted" is shown without those 
     common stock equivalents.
</FN>